SCHEMBL6806970

SCHEMBL6806970

Cc1ccc(-c2ccsn2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.50
POLB P06746 1/20 0.50
NOTUM Q6P988 1/20 0.50
METAP2 P50579 1/20 0.41
METAP1 P53582 1/20 0.41
ENPP3 O14638 1/20 0.39
ENPP1 P22413 1/20 0.39
NPC1 O15118 6/20 0.39
RAB9A P51151 6/20 0.39
SMN1; SMN2 Q16637 5/20 0.39
MEN1 O00255 4/20 0.39
MAPT P10636 4/20 0.39
KDM4E B2RXH2 3/20 0.39
SREBF2 Q12772 1/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
TP53 P04637 1/20 0.39
CYP1A2 P05177 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14754412 0.77 CYP19A1 (0.44) KMT2ANOTUMMETAP2NPC1RAB9A
SCHEMBL4587359 0.73 NPC1 (0.36) KMT2ANPC1RAB9ASMN1; SMN2MEN1
SCHEMBL10000254 0.67 NPC1 (0.61) KMT2APOLBNOTUMMETAP2METAP1
SCHEMBL12267118 0.67 KMT2A (0.44) KMT2APOLBNOTUMMETAP2METAP1
SCHEMBL6153838 0.67 KMT2A (1.00) KMT2APOLBNOTUMNPC1RAB9A
SCHEMBL10205815 0.65 CCR1 (0.55) KMT2APOLBNOTUMMETAP2METAP1
SCHEMBL197731 0.64 ACHE (0.73) ENPP3ENPP1CYP2C9CYP2C19ALDH1A1
SCHEMBL3287696 0.64 ACHE (0.73) ENPP3ENPP1CYP2C9CYP2C19ALDH1A1
SCHEMBL18661495 0.64 ACHE (0.73) ENPP3ENPP1CYP2C9CYP2C19ALDH1A1
SCHEMBL11118103 0.64 SMN1; SMN2 (0.43) KMT2APOLBNOTUMNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040097730-A1 Thrombin inhibitors MERCK & CO., INC. 2004-05-20 US disclosed
US-4636517-A 3-tolylthio-4-amino-4,5-dihydro isoxazole as anthelmintic INTERNATIONAL MINERALS & CHEMICAL CORP. (US) 1987-01-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040097730-A1 Thrombin inhibitors F3, F2, SERPINC1 KMT2A 3143/4885POLB 3900/4885NOTUM 1910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.